Activation of certain memory B cells may be driving systemic lupus erythematosus incidence in individuals who had ...

New findings could aid future development of more efficient therapeutic strategies in the context of regenerative medicine and aging.

New research suggests Alzheimer’s may start far earlier than previously thought, driven by a hidden toxic protein in the brain. Scientists found that an experimental drug, NU-9, blocks this early ...

Major histocompatibility complex class II (MHC-II) molecules play a critical, yet historically overlooked, role in tumor immunity.

Neuroscientist Steve Ramirez has found ways to plant memories in mice. Here's what that could mean for humans.

Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...

Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive effect against a ...

Explore the potential of experimental drug NU-9 in early Alzheimer's intervention, targeting toxic amyloid beta forms.

"David brings to Indaptus significant expertise, and I look forward to working with him to evaluate the ongoing business, identify business opportunities for the Decoy platform, and seek strategic ...

USC researchers have developed a new type of chimeric antigen receptor (CAR) T cell that elicits a more controlled immune response to cancer in mice—effectively killing cancer cells, including those ...

Researchers have engineered a next-generation glutamate sensor, iGluSnFR4, capable of detecting the faintest incoming ...